## Abstract Cytochrome P450 1B1 (CYP1B1) was recently shown to be a candidate tumor antigen broadly expressed in solid and hematologic malignancies. Nevertheless, use of such self‐antigens as targets for immune intervention can be limited because of loss of high‐avidity T cells during negative sele
Identification of a new hTERT-derived HLA-A*0201 restricted, naturally processed CTL epitope
✍ Scribed by Mette Thorn; Mingjun Wang; Henrik Kløverpris; Esben G. W. Schmidt; Anders Fomsgaard; Lynn Wenandy; Annika Berntsen; Søren Brunak; Søren Buus; Mogens H. Claesson
- Publisher
- Springer-Verlag
- Year
- 2007
- Tongue
- English
- Weight
- 429 KB
- Volume
- 56
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## MAGE -2 is expressed in many tumors, including melanoma, laryngeal tumors, lung tumors and sarcomas, but not in healthy tissue, with the exception of testis. Thus, MAGE-2derived peptides that bind to HLA class I molecules and elicit cytotoxic T lymphocyte (CTL) responses could be of significant
## Abstract Sperm protein 17 (Sp17) is a novel cancer‐testis antigen. We previously reported the successful generation of Sp17‐specific HLA‐A1‐restricted cytotoxic T‐lymphocytes (CTLs) from the peripheral blood of a healthy donor using a recombinant Sp17 protein. These CTLs were able to kill not on